Mark will lead the sales of all value added commercial services to individual pharmaceutical companies. Mark comes to Aegate from Cegedim where he was the Global VP of the Customer Information Unit. He has extensive experience in the sector and joined Cegedim when they acquired his former company, Dendrite. Prior to Cegedim Mark had developed his own venture in Pharmaceutical services which he later sold to Dendrite. He also brings further experience from working with both Sandoz and Eli Lilly.
Mark Kroes stated: "I am very excited to join an innovative company with great prospects of improving patient safety and helping the evolution of medicine adherence to therapy".
Mark De Simone, Aegate CEO, commented: "With Mark we are strengthening our leadership team and our ability to create services of increasingly higher value for our existing customer base".
(c) 2015 GlobalData Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers